BillionToOne's Northstar Select® Demonstrates Superior Sensitivity in Prospective Head

Powered by proprietary single-molecule next-generation sequencing (smNGS) technology, Northstar Select sets a new standard in sensitivity for non-invasive, blood-based comprehensive genomic profiling of advanced solid tumor cancers by uncovering over 50% more clinically actionable alterations compared to other tests